The Beneficial Role of Exercise on Treating Alzheimer’s Disease by Inhibiting β-Amyloid Peptide
Authors:
- 20 August 2021
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 58 (11) , 5890-5906
Abstract
Alzheimer’s disease (AD) is associated with a very large burden on global healthcare systems. Thus, it is imperative to find effective treatments of the disease. One feature of AD is the accumulation of neurotoxic β-amyloid peptide (Aβ). Aβ induces multiple pathological processes that are deleterious to nerve cells. Despite the development of medications that target the reduction of Aβ to treat AD, none has proven to be effective to date. Non-pharmacological interventions, such as physical exercise, are also being studied. The benefits of exercise on AD are widely recognized. Experimental and clinical studies have been performed to verify the role that exercise plays in reducing Aβ deposition to alleviate AD. This paper reviewed the various mechanisms involved in the exercise-induced reduction of Aβ, including the regulation of amyloid precursor protein cleaved proteases, the glymphatic system, brain-blood transport proteins, degrading enzymes and autophagy, which is beneficial to promote exercise therapy as a means of prevention and treatment of AD and indicates that exercise may provide new therapeutic targets for the treatment of AD.Keywords
Funding Information
- National Natural Science Foundation of China (82072531)
This publication has 182 references indexed in Scilit:
- Neuronal β‐amyloid generation is independent of lipid raft association of β‐secretase BACE1: analysis with a palmitoylation‐deficient mutantBrain and Behavior, 2012
- Neurotoxicity of Amyloid -Protein: Synaptic and Network DysfunctionCold Spring Harbor Perspectives in Medicine, 2012
- Amyloid Precursor Protein Processing and Alzheimer's DiseaseAnnual Review of Neuroscience, 2011
- Copper Promotes the Trafficking of the Amyloid Precursor ProteinJournal of Biological Chemistry, 2011
- Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brainJournal of Neurochemistry, 2010
- Activation of PERK Signaling Attenuates Aβ-Mediated ER StressPLOS ONE, 2010
- Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer’s diseaseActa Neuropathologica, 2009
- The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in miceJournal of Clinical Investigation, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Clearance of amyloid-β by circulating lipoprotein receptorsNature Medicine, 2007